ViennaLab Diagnostics
Private Company
Funding information not available
Overview
ViennaLab Diagnostics is a private, revenue-generating company that develops and distributes molecular diagnostic assays through an international network. Its core technology platforms include StripAssays®, RealFast™ assays, and NGS assays, offering solutions ranging from simple single-marker detection to complex genetic analysis. As part of the BioVendor Group, it leverages broader R&D and distribution capabilities while maintaining a focus on user-friendly, regulated IVD products for clinical laboratories. The company operates in the growing markets of personalized medicine and genetic testing.
Technology Platform
Three core platforms: 1) StripAssays® (membrane-based array for simple, multi-variant detection), 2) RealFast™ assays (real-time PCR for targeted, quantitative analysis), and 3) NGS assays (next-generation sequencing for complex genomic profiling).
Opportunities
Risk Factors
Competitive Landscape
ViennaLab competes in the crowded molecular diagnostics market against global giants (e.g., Roche, Qiagen, Thermo Fisher) and numerous specialized firms. Its differentiation lies in a focus on user-friendly, CE/IVD assays across multiple technology platforms and its distribution reach as part of the BioVendor Group.